SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy

Allogeneic hematopoietic stem cell transplantation (HSCT) is an established treatment option for high-risk hematological malignancies, and may also be offered to patients with solid malignancies refractory to conventional therapies. In case of patients’ relapse, refractory tumor cells may then be ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Rettinger, Eva, Glatthaar, Andreas, Abhari, Behnaz Ahangarian, Oelsner, Sarah, Pfirrmann, Verena, Huenecke, Sabine, Kuçi, Selim, Kreyenberg, Hermann, Willasch, Andre M., Klingebiel, Thomas, Fulda, Simone, Bader, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103003/
https://www.ncbi.nlm.nih.gov/pubmed/25101252
http://dx.doi.org/10.3389/fped.2014.00075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103003/
https://www.ncbi.nlm.nih.gov/pubmed/25101252
http://dx.doi.org/10.3389/fped.2014.00075

Ejemplares similares